end stage pancreatic cancer

[Celebration]

Interesting lecture by MD on an end stage pancreatic cancer patient treated by Dr. Berkson, using LDN and intravenous alpha lipoic acid

Some of his results have been published

http://www.ncbi.nlm.nih.gov/pubmed/20042414

The authors, in a previous article, described the long-term survival of a man with pancreatic cancer and metastases to the liver, treated with intravenous alpha-lipoic acid and oral low-dose naltrexone (ALA/N) without any adverse effects. He is alive and well 78 months after initial presentation. Three additional pancreatic cancer case studies are presented in this article. At the time of this writing, the first patient, GB, is alive and well 39 months after presenting with adenocarcinoma of the pancreas with metastases to the liver.......snip........This is the second article published on the ALA/N protocol and the authors believe the protocol warrants clinical trial.

[grasswire]

1. what is naltrexone?

My mother died three months after being diagnosed with pancreatic cancer. Of course, this was in 1987 and I assume treatments are light years ahead of what she was given.

[Celebration]

2. naltrexone is a very old drug

It is traditionally used to help get people off alcohol. It is an opiate antagonist. A number of doctors are now using it for cancer and autoimmune diseases, not in the traditional amounts, but in very low doses. Because of various published studies, it is probably used most for Crohn's Disease. The mechanism of high dose naltrexone is different from low dose naltrexone.

http://www.cosmicpenguin.com/ldn/

But this doctor has had published results for more than one end stage pancreatic cancer patient, using low dose naltrexone and intravenous alpha lipoic acid.